EMPACON MET 5/1000 TABLET

Product Description

EMPACON MET 5/1000 TabletAdvanced Dual Therapy for Type 2 Diabetes Management Trusted by Healthcare Providers NationwideProduct Description: EMPACON MET 5/1000 Tablet is a potent oral anti-diabetic formulation that combines the synergistic effects of Empagliflozin (5 mg) and Metformin Hydrochloride (1000 mg). Designed to deliver superior glycemic control, this fixed-dose combination helps manage blood sugar levels effectively in adults with type 2 diabetes mellitus, especially when monotherapy is inadequate.Composition (Per Tablet): Empagliflozin 5 mg Metformin Hydrochloride 1000 mg Excipients q.s. Key Benefits: Dual Mechanism of Action: Empagliflozin (SGLT2 inhibitor) promotes glucose excretion via urine, while Metformin improves insulin sensitivity and reduces hepatic glucose production. Improved Glycemic Control: Helps lower both fasting and postprandial blood sugar levels. Weight-Neutral & Cardio-Protective: Supports cardiovascular health and may assist in modest weight reduction. Once/Twice Daily Convenience: Enhances patient compliance and long-term treatment success. Usage/Application: Indicated for adults with type 2 diabetes mellitus as an adjunct to diet and exercise. Ideal for use in clinical settings, pharmacies, diabetes care centers, and hospitals. Prescription-only medication to be used under medical supervision. Target Buyers: Pharmaceutical distributors Retail chemists & druggists Hospital procurement units Bulk buyers & stockists Packaging: Secure blister or strip packing with clear dosage labeling for safe dispensing and handling. Partner with AGROSAF Where Innovation Meets Therapeutic Excellence. For bulk pricing, dealership opportunities, or institutional supply, contact us today.